SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001325812-14-000026
Filing Date
2014-03-04
Accepted
2014-03-04 20:49:27
Documents
1
Period of Report
2014-02-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 7181
  Complete submission text file 0001325812-14-000026.txt   8844
Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 857-242-3700
Sarepta Therapeutics, Inc. (Issuer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 333 RIVER STREET #303 HOBOKEN NJ 07030
Business Address
Christopher Nishan Garabedian (Reporting) CIK: 0001492604 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14895 | Film No.: 14667155